The likelihood of cancerous transformation in ulcerative colitis is not very high. Generally, patients with ulcerative colitis who have had the disease for more than a decade and have not undergone treatment might be at risk of malignancy. Active treatment and regular gastroscopic checks can prevent the development of cancer. Therapeutically, options include using mesalazine for anti-inflammatory treatment, as well as using Bacillus cereus or Bifidobacterium triplex to regulate the intestinal flora. Additionally, if a patient with ulcerative colitis experiences chills, fever, and severe purulent bloody stools, it may be necessary to consider treatment with steroids and immunosuppressants. (Please use medication under the guidance of a physician.)